Cargando…

Metabolic Reprogramming of Castration-Resistant Prostate Cancer Cells as a Response to Chemotherapy

Prostate cancer at the castration-resistant stage (CRPC) is a leading cause of death among men due to resistance to anticancer treatments, including chemotherapy. We set up an in vitro model of therapy-induced cancer repopulation and acquired cell resistance (CRAC) on etoposide-treated CRPC PC3 cell...

Descripción completa

Detalles Bibliográficos
Autores principales:	Petrella, Greta, Corsi, Francesca, Ciufolini, Giorgia, Germini, Sveva, Capradossi, Francesco, Pelliccia, Andrea, Torino, Francesco, Ghibelli, Lina, Cicero, Daniel Oscar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9865398/ https://www.ncbi.nlm.nih.gov/pubmed/36676990 http://dx.doi.org/10.3390/metabo13010065

Ejemplares similares

Androgen Deprivation Freezes Hormone-Sensitive Prostate Cancer Cells in a Reversible, Genetically Unstable Quasi-Apoptotic State, Bursting into Full Apoptosis upon Poly(ADP-ribose) Polymerase Inhibition
por: Pelliccia, Andrea, et al.
Publicado: (2023)

Apoptosis as Driver of Therapy-Induced Cancer Repopulation and Acquired Cell-Resistance (CRAC): A Simple In Vitro Model of Phoenix Rising in Prostate Cancer
por: Corsi, Francesca, et al.
Publicado: (2022)

Urinary Metabolic Markers of Bladder Cancer: A Reflection of the Tumor or the Response of the Body?
por: Petrella, Greta, et al.
Publicado: (2021)

Safe-Shields: Basal and Anti-UV Protection of Human Keratinocytes by Redox-Active Cerium Oxide Nanoparticles Prevents UVB-Induced Mutagenesis
por: Corsi, Francesca, et al.
Publicado: (2023)

The Interplay between Oxidative Phosphorylation and Glycolysis as a Potential Marker of Bladder Cancer Progression
por: Petrella, Greta, et al.
Publicado: (2020)

Unraveling Pathophysiology of Takotsubo Syndrome: The Emerging Role of the Oxidative Stress’s Systemic Status
por: Viceconte, Nicola, et al.
Publicado: (2022)

A Pilot Study on the (1)H-NMR Serum Metabolic Profile of Takotsubo Patients Reveals Systemic Response to Oxidative Stress
por: Vanni, Domitilla, et al.
Publicado: (2021)

Personalized Metabolic Profile by Synergic Use of NMR and HRMS
por: Petrella, Greta, et al.
Publicado: (2021)

The Impressive Anti-Inflammatory Activity of Cerium Oxide Nanoparticles: More than Redox?
por: Corsi, Francesca, et al.
Publicado: (2023)

The Role of Histology-Agnostic Drugs in the Treatment of Metastatic Castration-Resistant Prostate Cancer
por: Iannantuono, Giovanni Maria, et al.
Publicado: (2022)

Not Only Redox: The Multifaceted Activity of Cerium Oxide Nanoparticles in Cancer Prevention and Therapy
por: Corsi, Francesca, et al.
Publicado: (2018)

SQLE Mediates Metabolic Reprogramming to Promote LN Metastasis in Castration-Resistant Prostate Cancer
por: Xu, Zhenzhou, et al.
Publicado: (2021)

Chemotherapy options in castration-resistant prostate cancer
por: Teply, Benjamin A., et al.
Publicado: (2016)

Transdermal estradiol in castrate and chemotherapy resistant prostate cancer
por: Stein, Mark, et al.
Publicado: (2012)

Role of Chemotherapy and Mechanisms of Resistance to Chemotherapy in Metastatic Castration-Resistant Prostate Cancer
por: Lohiya, Vipin, et al.
Publicado: (2016)

Metabolic Reprogramming by Malat1 Depletion in Prostate Cancer
por: Nanni, Simona, et al.
Publicado: (2020)

Emerging Hallmarks of Metabolic Reprogramming in Prostate Cancer
por: Lasorsa, Francesco, et al.
Publicado: (2023)

Hormonal therapy and chemotherapy in hormone-naive and castration resistant prostate cancer
por: Recine, Federica, et al.
Publicado: (2015)

Metabolic reprogramming as an emerging mechanism of resistance to endocrine therapies in prostate cancer
por: Chetta, Paolo, et al.
Publicado: (2021)

Humulus lupulus Cone Extract Efficacy in Alginate-Based Edible Coatings on the Quality and Nutraceutical Traits of Fresh-Cut Kiwifruit
por: Carbone, Katya, et al.
Publicado: (2021)

A Camera Sensors-Based System to Study Drug Effects on In Vitro Motility: The Case of PC-3 Prostate Cancer Cells
por: Comes, Maria Colomba, et al.
Publicado: (2020)

Castration for Prostatic Hypertrophy
Publicado: (1899)

Population-based study on use of chemotherapy in men with castration resistant prostate cancer
por: Lissbrant, Ingela Franck, et al.
Publicado: (2013)

Budget Impact of Enzalutamide for Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer
por: Bui, Cat N., et al.
Publicado: (2016)

Metabolic reprogramming in prostate cancer
por: Ahmad, Fahim, et al.
Publicado: (2021)

Nutrition, metabolism, and epigenetics: pathways of circadian reprogramming
por: Sato, Tomoki, et al.
Publicado: (2022)

Cerium Oxide Nanoparticles Re-establish Cell Integrity Checkpoints and Apoptosis Competence in Irradiated HaCat Cells via Novel Redox-Independent Activity
por: Caputo, Fanny, et al.
Publicado: (2018)

Editorial: Tumor Systems Biology: How to Therapeutically Redirect Dysregulated Homeostasis in Tumor Systems (i.e., Anakoinosis)
por: Reichle, Albrecht, et al.
Publicado: (2020)

Recent Progress in Pharmaceutical Therapies for Castration-Resistant Prostate Cancer
por: Yin, Lina, et al.
Publicado: (2013)

Prostatic Neoplasia in the Intact and Castrated Dog: How Dangerous is Castration?
por: Schrank, Magdalena, et al.
Publicado: (2020)

Circulating microRNAs are associated with docetaxel chemotherapy outcome in castration-resistant prostate cancer
por: Lin, H-M, et al.
Publicado: (2014)

Importance of cycles of chemotherapy and postdocetaxel novel therapies in metastatic castration-resistant prostate cancer
por: Poon, Darren M.C., et al.
Publicado: (2015)

Reinduction of Hormone Sensitivity to Goserelin following Chemotherapy with Vinorelbine in Castration-Resistant Prostate Cancer
por: Grenader, Tal, et al.
Publicado: (2010)

Dynamic changes in gene alterations during chemotherapy in metastatic castrate resistant prostate cancer
por: Tan, Winston, et al.
Publicado: (2022)

The effect of chemotherapy on the exposure–response relation of abiraterone in metastatic castration‐resistant prostate cancer
por: Boerrigter, Emmy, et al.
Publicado: (2021)

Increased AR expression in castration-resistant prostate cancer rapidly induces AR signaling reprogramming with the collaboration of EZH2
por: Labaf, Maryam, et al.
Publicado: (2022)

Impact of Somatic DNA Repair Mutations on the Clinical Outcomes of Bone Metastases from Castration-Resistant Prostate Cancer
por: Cursano, Maria Concetta, et al.
Publicado: (2023)

Castration for Hypertrophy of the Prostate Gland
Publicado: (1895)

The role of glutamine metabolism in castration-resistant prostate cancer
por: Zhao, Bing, et al.
Publicado: (2023)

Anakoinosis: Communicative Reprogramming of Tumor Systems - for Rescuing from Chemorefractory Neoplasia
por: Hart, Christina, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_0ok7fu1e2fs6ifsccghd3biugg